For instance, APS significantly enhanced the inhibitory effects of apatinib on VEGFR-2–positive cells in gastric and pancreatic cancers, potentially through inhibition of the AKT/ERK signaling pathways and induction of autophagy (Wu et al., 2018a; Wu et al., 2018b). This evidence concerns the gene KDR and pancreatic neoplasm.